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Elephant in the Room
Look at the Red Blood CellsWe read with great interest the paper by Silvain et al. (1) on the
impact of red blood cell transfusion on platelet aggregation and in-
ﬂammatory response in anemic coronary and noncoronary patients.
The authors should be commended on a well-planned and well-
conducted study regarding a somewhat neglected aspect of
our therapeutic practice. We would like to point out, however, that
much of the discussion surrounding this and other related reports on
red blood cell transfusions in patients with heart disease is focused on
how they affect platelet function and other aspects of the coagulation
system. However, we should not miss the giant elephant in the
roomdthe red blood cells themselves. By transfusing blood to pa-
tients, we administer some billions of red blood cells that have been
submitted to a tedious procedure of collection, processing, and
storage in packed red blood cell units. This process is known to
produce alterations that lead to hemolysis and the formation
of erythrocyte microparticles (2). Free hemoglobin is an extremely
oxidative and vasospastic agent, and red blood cell microparticles
have been shown to be associated with endothelial dysfunction and
prothrombotic phenomena (3,4). As a result, red blood cells them-
selves (with no need to affect platelets in any signiﬁcant way) may
be a major determinant of transfusion adverse effects on cardiovas-
cular outcomes. This may also explain, at least in part, why the
authors found no connection between the storage duration of blood
units with platelet aggregation parameters: storage affects red blood
cells, which in turn may lead to the described unwanted cardiovas-
cular effects, in a way virtually unrelated to platelet function.*Georgios Giannopoulos, MD
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65:1164–73.ReplyDo Not Miss the
Elephant in the Room
Look at the Red Blood CellsWe thank Drs. Giannopoulos and Deftereos for their excellent
comments on the potential role of red blood cells (RBCs) as an
explanation for the excess of risk due to RBC transfusion.
We share their view on this point as data show an association
between cell-free, hemoglobin-based blood substitutes and the
risk of myocardial infarction and death (1) that is very similar to
the one found in registries between RBC transfusion and poor
outcomes in coronary patients. Unfortunately, we lack evidence on
the impact of cell-free hemoglobin through endothelial dysfunc-
tion and prothrombotic effects in patients receiving a RBC
transfusion.
We believe that activation of the P2Y purinergic receptors
is one of the relevant mechanisms, as demonstrated in our pre-
vious in vitro study (2). Indeed, platelet reactivity was increased
using different assays including light transmission aggregometry
to adenosine diphosphate (ADP), collagen, and vasodilator-
stimulated phosphoprotein phosphorylation platelet reactivity
index (VASP-PRI), highly speciﬁc tests suggesting a partial
activation of the P2Y12 receptors. We concluded that the
release of ADP from RBCs might be readily liberated in the
context of blood storage, thus representing a potential stimulus
for platelet activation and aggregation. The results of the
TRANSFUSION-2 study (3) support this hypothesis as the
impact on platelet reactivity was found only with tests exploring
